Nicholas J. Sarlis

Nicholas J. Sarlis

Chief Tech/Sci/R&D Officer at Sellas Life Sciences Group Ltd.

59 year
Health Technology
Consumer Services

Profile

Nicholas J.
Sarlis
is currently the Chief Medical Officer & Senior Vice President at Sellas Life Sciences Group Ltd.
He previously worked as the Vice President & Head-Global Medical Affairs at Incyte Corp.
from 2010 to 2016.
Prior to that, he was an Associate Professor at The University of Texas M.D.
Anderson Cancer Center from 2002 to 2006 and later returned to the same institution as an Associate Professor.
He also served as the Chief Medical Officer & Executive Vice President at SELLAS Life Sciences Group, Inc. from 2017 to 2020.
Sarlis earned his doctorate from the University of London in 1992 and his undergraduate and another doctorate degree from National & Kapodistrian University of Athens in 1988 and 1989, respectively.

Nicholas J. Sarlis active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer -
All active positions of Nicholas J. Sarlis

Former positions of Nicholas J. Sarlis

CompaniesPositionEnd
SELLAS LIFE SCIENCES GROUP, INC. Chief Tech/Sci/R&D Officer 2020-02-29
INCYTE CORPORATION Chief Tech/Sci/R&D Officer 2016-04-30
Corporate Officer/Principal 2005-12-31
Corporate Officer/Principal -
See the detail of Nicholas J. Sarlis's experience

Training of Nicholas J. Sarlis

National & Kapodistrian University of Athens Doctorate Degree
University of London Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nicholas J. Sarlis's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
SELLAS LIFE SCIENCES GROUP, INC.

Health Technology

INCYTE CORPORATION

Health Technology

Private companies2

Health Technology

Consumer Services

See company connections
  1. Stock Market
  2. Insiders
  3. Nicholas J. Sarlis
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW